🔍

MEDIASSIST - Medi Assist Ser.

📊 NSE: MEDIASSIST 🏢 Miscellaneous 📅 Last Updated: 12/14/2025 9:44

📢 Recent Corporate Announcements

Medi Assist Shareholders Approve Appointment of Sunita Rebecca Cherian as Director with 99.46% Votes

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 27 Apr 2026, 03:17 PM

Medi Assist Healthcare Services Limited has successfully passed an ordinary resolution via postal ballot for the appointment of Ms. Sunita Rebecca Cherian as a Non-Executive, Non-Independent Director. The voting process, which concluded on April 26, 2026, saw participation from a shareholder base of 93,083. A total of 55,311,281 valid votes were cast, with an overwhelming 99.4555% in favor of the appointment. This move strengthens the company's board following the requisite majority approval from its members.

Appointment of Ms. Sunita Rebecca Cherian as Non-Executive, Non-Independent Director approved by shareholders.
Resolution passed with 55,010,122 votes in favor, representing 99.4555% of total valid votes.
Only 301,159 votes (0.5445%) were cast against the resolution.
Total valid votes polled amounted to 55,311,281 out of a total shareholder count of 93,083 as of the cut-off date.
The resolution is deemed approved as of April 26, 2026, the final date of the e-voting period.

💡 This is a routine governance update regarding board composition and requires no immediate action from investors. The high approval rating indicates strong shareholder confidence in the board's selection.

Medi Assist Healthcare Submits Routine SEBI Compliance Certificate for Q4 FY26

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 10 Apr 2026, 12:39 PM

Medi Assist Healthcare Services Limited has submitted its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited, confirmed that no requests for dematerialization or rematerialization were received during the quarter ended March 31, 2026. This filing confirms that all securities of the company are currently held in dematerialized mode, ensuring compliance with standard regulatory requirements.

Compliance certificate filed for the quarter ended March 31, 2026.
Zero requests for dematerialization or rematerialization received between January 1, 2026, and March 31, 2026.
Confirmation that 100% of the company's securities are held in dematerialized mode.
The filing was processed by Registrar MUFG Intime India Private Limited.

💡 No action is required as this is a routine administrative filing confirming standard regulatory compliance regarding shareholding records.

Medi Assist Allots 92,415 Equity Shares Under ESOP Scheme

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 03 Apr 2026, 09:54 AM

Medi Assist Healthcare Services has approved the allotment of 92,415 equity shares to an eligible employee following the exercise of stock options under its 2013 ESOP scheme. The shares were issued at exercise prices of Rs. 256 and Rs. 273 per share. This allotment has increased the company's total paid-up equity share capital from Rs. 37.30 crore to approximately Rs. 37.35 crore. The new shares will rank pari-passu with existing equity shares and represent a marginal dilution of the existing shareholding.

Allotment of 92,415 equity shares with a face value of Rs. 5 each
Exercise prices for the options were fixed at Rs. 256 and Rs. 273 per share
Total paid-up equity shares increased from 7,46,09,427 to 7,47,01,842
Post-allotment paid-up capital stands at Rs. 37,35,09,210
The allotment was approved by the Nomination and Remuneration Committee via circular resolution

💡 This is a routine corporate action with negligible impact on share value due to minimal dilution (approx 0.12%). No specific action is required from investors.

Medi Assist Gets NSE/BSE Nod to Reclassify 6 Promoter Entities to Public Category

🟡 NEUTRAL ⭐ 4/10

REGULATORY 📅 02 Apr 2026, 06:54 PM

Medi Assist Healthcare Services has received No-Objection letters from both NSE and BSE for the reclassification of six entities from the 'promoter and promoter group' to the 'public' category. The entities include Bessemer India Capital Holdings II Ltd, Perfios Software Solutions, and Lentra AI, among others. This regulatory approval follows the company's application submitted in February 2026. Such reclassifications typically occur when early-stage investors or institutional backers no longer exercise control or hold management rights in the company.

Approval received from NSE and BSE on April 2, 2026, for the reclassification of 6 entities.
Bessemer India Capital Holdings II Ltd moves from 'Promoter' to 'Public' category.
Other entities like Perfios Software Solutions and Lentra AI move from 'Promoter Group' to 'Public'.
The reclassification is executed under Regulation 31A of SEBI (LODR) Regulations, 2015.
This follows the company's formal application process initiated on February 10, 2026.

💡 Investors should monitor the shareholding pattern in future quarters as reclassified public shareholders may find it easier to trim their stakes. No immediate action is required as this is a standard regulatory procedure.

Medi Assist to Close Trading Window from April 1, 2026, for Q4 FY26 Results

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 27 Mar 2026, 12:28 PM

Medi Assist Healthcare Services Limited has announced the closure of its trading window starting April 1, 2026, in compliance with SEBI Prohibition of Insider Trading Regulations. This closure is ahead of the declaration of the audited financial results for the quarter and financial year ending March 31, 2026. The window will remain closed for all designated persons and their immediate relatives until 48 hours after the results are made public. The specific date for the board meeting to approve these results will be communicated at a later date.

Trading window closure effective from April 1, 2026.
Closure pertains to the audited financial results for Q4 and the full financial year ending March 31, 2026.
Trading restriction ends 48 hours after the official announcement of financial results.
Compliance follows SEBI (Prohibition of Insider Trading) Regulations, 2015.

💡 This is a routine regulatory announcement and does not impact the company's fundamentals. Investors should monitor for the upcoming board meeting date to assess the company's year-end financial performance.

CARE Reaffirms 'AA-; Stable' Rating for Medi Assist Subsidiary; Market Share Hits 21.3%

🟢 POSITIVE ⭐ 7/10

ROUTINE 📅 12 Mar 2026, 12:01 PM

CARE Ratings has reaffirmed the 'CARE AA-; Stable' rating for Medi Assist's key subsidiary, MAITPA, following its ₹412 crore acquisition of Paramount TPA. The company successfully repaid its ₹150 crore bridge debt by January 2026, returning to a nil external debt position. While the group insurance market share has surged to 32.2%, operating margins have moderated to 13.67% due to higher software fees and integration costs. Total Premiums Under Management (PUM) are projected to reach ₹26,500 crore in FY26, reflecting strong inorganic growth.

CARE reaffirmed 'AA-; Stable' and 'A1+' ratings for bank facilities totaling ₹266 crore.
Market share in the TPA industry reached 21.3% overall and 32.2% in the group segment post-acquisition.
Successfully repaid ₹150 crore bridge debt used for the Paramount TPA acquisition as of January 15, 2026.
Premiums Under Management (PUM) expected to grow to ₹26,500 crore in FY26 from ₹21,108 crore in FY25.
Operating margins moderated to 13.67% in FY25, with a recovery target of 12-13% in the medium term.

💡 The rating reaffirmation validates the company's financial discipline in managing large acquisitions without stretching the balance sheet. Investors should monitor the realization of synergy benefits from the Paramount TPA integration to see if margins return to historical levels.

Medi Assist Subsidiary Pays INR 4.83 Crore to Conclude GST Search Operation

🟡 NEUTRAL ⭐ 6/10

REGULATORY 📅 03 Mar 2026, 04:58 PM

Medi Assist Healthcare's material subsidiary, Medi Assist TPA, has concluded a GST search operation conducted by the Maharashtra Department of Goods and Services Tax. The company paid a total of INR 4.83 Crores to settle liabilities arising from a supplier's failure to remit taxes and interest on holdback amounts. This payment was made 'without prejudice' to avoid further penalties, allowing the company to pursue legal remedies or recovery later. Management has confirmed that business operations remain unaffected and there is no further material financial impact.

GST search operation at Mumbai office concluded on March 2, 2026, following its initiation on February 16, 2026.
Total payment of INR 4.83 Crores made covering aggregate unpaid tax and interest liabilities.
Liability triggered by a defaulting supplier's non-remittance of taxes and interest on customer invoice holdbacks.
Payment made without prejudice to the subsidiary's rights to file representations or seek recovery.
Company reports no material impact on operations or other financial activities beyond the stated payment.

💡 The settlement amount is relatively small compared to the company's scale, and the conclusion of the search removes regulatory uncertainty. Investors should view this as a routine tax compliance resolution with minimal impact on long-term fundamentals.

Medi Assist Expands to Southeast Asia via Strategic AI-Tech Partnership with LawtonAsia

🟢 POSITIVE ⭐ 7/10

EXPANSION 📅 27 Feb 2026, 03:23 PM

Medi Assist Healthcare Services has entered a strategic partnership with Thailand-based LawtonAsia to deploy its AI-powered health-tech platform in Southeast Asia. This collaboration allows LawtonAsia to use Medi Assist's proprietary systems for medical insurance claims management and flexible benefit plans. The move aligns with Medi Assist's global expansion strategy, leveraging its technology stack to serve international markets. Implementation is currently underway in Thailand, with a full launch expected within the coming weeks.

Strategic partnership with LawtonAsia to bring AI-driven health-tech to the Thailand market.
Deployment of proprietary platform to streamline claims processing and enhance transparency.
Enables corporate clients to manage flexible benefit plans within insurance programs.
Implementation phase has commenced with a full 'go-live' expected in the coming weeks.

💡 Investors should monitor the successful execution of this partnership as it demonstrates the scalability of Medi Assist's tech platform beyond India. Positive outcomes could lead to further international contracts and improved margins.

Medi Assist Allots 1,51,685 Equity Shares via ESOP Exercise

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 26 Feb 2026, 09:16 AM

Medi Assist Healthcare Services has approved the allotment of 1,51,685 equity shares to employees under its Employee Stock Option Scheme 2013. This move increases the total number of outstanding shares from 7,44,57,742 to 7,46,09,427. The shares were issued at exercise prices ranging from Rs. 256 to Rs. 281. Consequently, the total paid-up equity capital of the company has risen to approximately Rs. 37.30 crore.

Allotment of 1,51,685 equity shares of face value Rs. 5 each to eligible employees.
Total paid-up equity share capital increased from Rs. 37,22,88,710 to Rs. 37,30,47,135.
Exercise prices for the options were fixed at Rs. 256, Rs. 273, and Rs. 281 per share.
The new shares rank pari-passu with the existing equity shares of the company.

💡 This is a routine administrative allotment with negligible equity dilution of approximately 0.2%. No specific action is required from investors.

Medi Assist Shareholders Approve Re-appointment of CEO and Chairman for 5-Year Terms

🟢 POSITIVE ⭐ 7/10

MANAGEMENT 📅 25 Feb 2026, 03:48 PM

Medi Assist Healthcare Services Limited has announced the successful passage of five key resolutions via postal ballot with overwhelming shareholder support. Dr. Vikram Jit Singh Chhatwal has been re-appointed as Chairman and Whole-Time Director for a five-year term starting March 1, 2026, with 98.64% votes in favor. Similarly, Mr. Satish V N Gidugu was re-appointed as CEO and Whole-Time Director for five years with 99.61% approval. The resolutions also secured the re-appointment of an Independent Director and approved executive remuneration for the next three years.

Dr. Vikram Jit Singh Chhatwal re-appointed as Chairman and WTD for 5 years with 98.64% votes in favor
Mr. Satish V N Gidugu re-appointed as CEO and WTD for 5 years with 99.61% votes in favor
Dr. Ritu Niraj Anand re-appointed as Independent Director for a second 5-year term with 99.99% approval
Executive remuneration for both the Chairman and CEO approved for a 3-year period effective March 1, 2026
Total of 53,523,094 votes were polled across institutional and non-institutional categories

💡 Investors should view this as a positive sign of leadership stability and continuity in the company's strategic direction. The high approval ratings indicate strong institutional confidence in the current management team.

GST Department Initiates Search at Medi Assist TPA's Mumbai Office

🔵 WATCH ⭐ 6/10

REGULATORY 📅 17 Feb 2026, 01:06 PM

The Department of Goods and Services Tax, Maharashtra, has initiated a search operation at the Mumbai office of Medi Assist Insurance TPA Private Limited, a material wholly-owned subsidiary of Medi Assist Healthcare Services. The search, conducted under Section 67 of the CGST Act, 2017, commenced on February 16, 2026. While the company claims that business operations remain unaffected and no immediate financial impact is anticipated, the proceedings are currently ongoing. Investors should remain cautious as the final outcome regarding potential tax liabilities or penalties is yet to be determined.

Search operation initiated by Maharashtra GST Department at the Mumbai office of Medi Assist Insurance TPA Private Limited.
Action taken under Section 67 of the Central Goods and Service Tax Act, 2017, starting February 16, 2026.
The target entity is a material wholly-owned subsidiary of the listed parent company.
Management states that business operations are currently unaffected and no financial impact is expected at this stage.

💡 Investors should monitor subsequent filings for any quantification of tax demands or penalties resulting from this search. Maintain a watch on the stock as regulatory actions on material subsidiaries can lead to short-term volatility.

Medi Assist Q3 FY26: Consolidated Revenue Up 29.9%, Company Becomes Debt-Free

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 12 Feb 2026, 05:46 PM

Medi Assist Healthcare Services reported a robust Q3 FY26 with consolidated total income rising 29.9% YoY, significantly aided by the Paramount acquisition. The company successfully transitioned to a debt-free status in January 2026, having reduced debt from INR 243 crores in September 2025. Operational efficiency improved as Paramount's standalone margins expanded by 557 bps QoQ, while tech-driven fraud prevention (MAven Guard) saved INR 400 crores. The group market share reached a significant 32.2%, reflecting strong organic and inorganic growth.

Consolidated total income grew 29.9% YoY in Q3 FY26, with 9M FY26 income up 23.5% to INR 128.9 crores.
Achieved debt-free status in January 2026, down from a debt of INR 243 crores in September 2025.
Group market share increased to 32.2%, representing a 307 bps year-on-year improvement.
Technology revenues surged 81.5% YoY, with the MAven Guard platform preventing INR 400 crores in fraud.
Paramount integration is on track with a slump transfer of business effective February 1, 2026.

💡 Investors should take note of the rapid deleveraging and successful integration of Paramount which is driving margin expansion. The strong growth in high-margin tech-led revenues and dominant market share in the group segment makes it a compelling play in the TPA space.

Medi Assist Files for Reclassification of Bessemer and Others to Public Category

🟡 NEUTRAL ⭐ 4/10

REGULATORY 📅 11 Feb 2026, 01:55 PM

Medi Assist Healthcare Services has formally applied to BSE and NSE for the reclassification of six entities from the 'promoter and promoter group' to the 'public' category. The entities involved include Bessemer India Capital Holdings II Ltd and Perfios Software Solutions, all of which currently hold zero shares in the company. This move follows the Board's approval granted on February 6, 2026. The reclassification is a procedural step under SEBI LODR regulations as these entities no longer hold any stake or control in the firm.

Application filed with BSE and NSE on February 10, 2026, for promoter reclassification.
Six entities, including Bessemer India Capital Holdings II Ltd and Lentra AI, are moving to the public category.
All six entities currently hold NIL equity shares, representing 0% shareholding in the company.
The reclassification follows the Board of Directors' approval obtained on February 6, 2026.

💡 This is a routine regulatory procedure with no impact on the company's actual shareholding pattern or operations. Investors should treat this as a neutral administrative update.

CARE Reaffirms Medi Assist Rating at 'AA-; Stable'; Company Repays Entire ₹150 Cr Bridge Debt

🟢 POSITIVE ⭐ 7/10

ROUTINE 📅 10 Feb 2026, 04:17 PM

CARE Ratings has reaffirmed Medi Assist's long-term rating at 'CARE AA-; Stable', reflecting its dominant 21.3% market share in the TPA industry. The company has successfully repaid its entire ₹150 crore bridge debt used for the ₹412 crore Paramount TPA acquisition, returning to a net debt-free status as of January 2026. Financial performance remains strong with Premiums Under Management (PUM) expected to reach ₹26,500 crore in FY26, supported by a 94% corporate retention rate. While integration of new acquisitions slightly compressed H1FY26 margins to 19.3%, profitability is expected to recover to the 21-22% range in the medium term.

CARE AA-; Stable and CARE A1+ ratings reaffirmed for bank facilities totaling ₹16 crore.
Successfully repaid ₹150 crore bridge debt by January 15, 2026, following a ₹198 crore preferential issue.
Market share in group insurance segment increased to 32.2% as of September 2025.
PUM projected to grow to ₹26,500 crore in FY26, up from ₹21,108 crore in FY25.
Maintains a robust network of over 20,000 hospitals and 10,500 corporate clients with 94% retention.

💡 Investors should take confidence in the company's ability to fund large acquisitions (Paramount TPA) and quickly return to a debt-free status. The reaffirmation of high credit ratings and dominant market share positions the company well for long-term growth in the health insurance sector.

Medi Assist Credit Rating Reaffirmed at CARE AA-; Stable; Company Now Debt-Free

🟢 POSITIVE ⭐ 7/10

ROUTINE 📅 10 Feb 2026, 12:27 PM

CARE Ratings has reaffirmed Medi Assist's credit rating at 'CARE AA-; Stable' for long-term and 'CARE A1+' for short-term facilities. The company has successfully integrated the ₹412 crore Paramount TPA acquisition and repaid its entire external debt of ₹150 crore as of January 2026. With a market share of 21.3% in the TPA industry, the company expects revenue growth of 27-28% in FY26. Despite a temporary dip in H1FY26 margins to 19.32%, synergy benefits are expected to restore margins to 21-22% in the medium term.

CARE Ratings reaffirmed 'CARE AA-; Stable' and 'CARE A1+' ratings for bank facilities totaling ₹16 crore.
Company is now debt-free after repaying ₹150 crore bridge debt used for the Paramount TPA acquisition.
Market share in the overall health TPA industry rose to 21.3% following strategic acquisitions.
Revenue growth is projected at 27-28% for FY26, driven by higher Premiums Under Management (PUM).
Preferential issue of ₹198 crore in October 2025 significantly strengthened the balance sheet and liquidity.

💡 The reaffirmation and debt-free status confirm strong financial management after a large acquisition. Investors should monitor the company's ability to maintain its 20%+ operating margins while scaling its market share.

View All MEDIASSIST Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Operating Revenue grew 28.6% YoY to INR 232.5 Cr in Q2 FY26. Segment contributions for H1 FY26 include Government business at 11.9%, International Benefits Administration at 4.9%, and Technology SaaS Services at 2.2%. The core TPA business remains the primary driver, with consolidated revenue for FY25 reaching INR 747.08 Cr, a 14.4% YoY increase.

Geographic Revenue Split

International operations through the International Benefits Administration business contributed 4.3% of revenue in Q2 FY26 and 4.9% in H1 FY26. The remaining ~95% is primarily domestic (India) across retail, corporate, and government segments.

Profitability Margins

Operating EBITDA margin stood at 17.1% in Q2 FY26 and 19.3% in H1 FY26. Reported PAT margin for Q2 FY26 was 3.4% (INR 8.1 Cr), significantly impacted by acquisition-related amortization and financing costs. Standalone PBT (excluding exceptional items) for FY25 was INR 44.55 Cr, up 21.18% YoY.

EBITDA Margin

Operating EBITDA margin was 17.1% in Q2 FY26, a decline from the historical 22% base. This was driven by a 150 bps impact from Paramount integration costs and a 100 bps impact from incremental technology investments. EBITDA grew 3.3% YoY to INR 39.7 Cr in Q2 FY26.

Capital Expenditure

Not explicitly disclosed in INR Cr for future periods, but the company is investing 100 bps of EBITDA margin into technology infrastructure and is currently 2 quarters into a 4-5 quarter SaaS implementation journey.

Credit Rating & Borrowing

Credit risk profile is strong with minimal debt obligations. Rating sensitivities require maintaining PBILDT margins of ~20% and TOI growth of 10-15%. The company expects to be debt-free by March-April 2026 using internal cash accruals.

⚙️ Operational Drivers

Raw Materials

Not applicable as Medi Assist is a service-based TPA; primary costs are employee benefits and technology infrastructure. Sub-contracting expenses decreased in FY25 due to improved in-house capability development.

Key Suppliers

Not applicable; however, the company relies on insurance partners and a network of hospitals for its TPA operations.

Capacity Expansion

Expansion is focused on market share and volume rather than physical units. The company is integrating Paramount and Raksha to increase its retail and corporate TPA footprint.

Raw Material Costs

Not applicable. Operational efficiency is tracked via sub-contracting costs and technology-led automation which reduces pass-through people costs in the SaaS segment.

Manufacturing Efficiency

Efficiency is driven by technology; the SaaS business is expected to be margin-accretive at steady state because it lacks the pass-through people costs associated with traditional TPA services.

Logistics & Distribution

Not applicable; service delivery is primarily digital and through a network of healthcare providers.

📈 Strategic Growth

Expected Growth Rate

10-15%

Growth Strategy

Growth will be achieved through the integration of Paramount (targeting a return to 22-23% EBITDA margins), expansion of the SaaS technology business (currently 2% of revenue), and increasing market share in the retail segment using AI-driven fraud detection tools.

Products & Services

Third Party Administration (TPA) services, International Benefits Administration, Technology SaaS Services, and AI-based fraud/abuse detection engines for insurers.

Brand Portfolio

Medi Assist, Paramount, Raksha.

New Products/Services

Fraud-based and abuse AI engine for independent use on insurer systems; SaaS technology services currently contributing 2.2% of H1 FY26 revenue.

Market Expansion

Expansion into international markets (currently 4.9% of H1 revenue) and deeper penetration into the Indian retail insurance market.

Market Share & Ranking

Maintains a leadership position in the Indian TPA market; specific percentage ranking not disclosed but cited as 'leadership position'.

Strategic Alliances

Acquisition of Paramount and Raksha to consolidate market leadership in the TPA space.

🌍 External Factors

Industry Trends

The TPA industry is shifting toward technology-integrated models and consolidation. Medi Assist is positioning itself as a tech-heavy player with SaaS and AI offerings to capture retail market share.

Competitive Landscape

Consolidated market with Medi Assist as a leader; competition includes other TPAs and in-house TPA wings of large insurance companies.

Competitive Moat

Moat is built on a 22% margin base business, proprietary technology stack (SaaS), and the scale of its hospital network. Sustainability is driven by the high switching costs of TPA platforms for insurers.

Macro Economic Sensitivity

Sensitive to health insurance penetration rates in India and government healthcare spending (Government business is 12.6% of Q2 revenue).

Consumer Behavior

Increased demand for retail health insurance and digital-first claim processing is driving demand for Medi Assist's tech-enabled TPA services.

Geopolitical Risks

Minimal, primarily affecting the 4.3% international benefits administration segment.

⚖️ Regulatory & Governance

Industry Regulations

Subject to IRDAI regulations for TPAs; compliance is managed through internal controls and a Whistle Blower Policy. No frauds were reported under Section 143 in FY25.

Taxation Policy Impact

Effective tax rate (ETR) increased in FY25, with total income tax expense rising 54.2% to INR 20.19 Cr due to improved profitability.

Legal Contingencies

No significant or material orders passed by regulators or courts impacting the company's going concern status were reported for FY25.

⚠️ Risk Analysis

Key Uncertainties

Integration risk of Paramount (150 bps margin impact), sustainability of the 22-23% EBITDA margin target, and the 4-5 quarter timeline for SaaS revenue realization.